Lauren Pommert (L Pommert)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

Cerebrospinal Fluid

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

Pediatric blood & cancer

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Francis R LeBlanc, Erin H Breese, Karen C Burns, Ellen K Chang, LaQuita M Jones, Lynn Lee, Benjamin Mizukawa, Robin E Norris, Maureen M O'Brien, Christine L Phillips, John P Perentesis, Jeremy D Rubinstein, Lauren Pommert
Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British journal of haematology (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Ashley N Chavana, Zachary L Taylor, Nicholas DeGroote, Holly B Lindsay, Hannah E Sauer, Emily J Mason, Eric S Schafer, Tamara P Miller, Sharon M Castellino, Lauren Pommert, Maureen M O'Brien, Laura B Ramsey, Melanie Brooke Bernhardt, Austin L Brown
Toxicity profile of high-dose methotrexate in young children with central nervous system tumors. Pediatric blood & cancer (2024)
Francis R LeBlanc, David D Grier, Kasiani C Myers, Akiko Shimamura, Lauren Pommert
A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric blood & cancer (2024)
Francis R LeBlanc, David D Grier, Kasiani C Myers, Akiko Shimamura, Lauren Pommert
A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome. Pediatric blood & cancer 71 (8) (2024)
Ashley N Chavana, Zachary L Taylor, Nicholas DeGroote, Holly B Lindsay, Hannah E Sauer, Emily J Mason, Eric S Schafer, Tamara P Miller, Sharon M Castellino, Lauren Pommert, Maureen M O'Brien, Laura B Ramsey, Melanie Brooke Bernhardt, Austin L Brown
Toxicity profile of high-dose methotrexate in young children with central nervous system tumors. Pediatric blood & cancer 71 (10) (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Nathan Gossai, Deepa Bhojwani, E S Schafer, Bill H Chang, Lauren Pommert, Anupam Verma, J Malvar, Y Y Chi, Johann K Hitzler, Michael J Burke, K R Rabin
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Jonathan D Bender, Jeremy D Rubinstein, Benjamin Mizukawa, John P Perentesis, Lauren Pommert
Use of gemcitabine, oxaliplatin, and anti-CD20 therapy in children and adolescents with non-Hodgkin lymphoma unfit for intensive therapy. Pediatric blood & cancer 70 (4) (2023)
Lauren Pommert, Todd M Cooper, Robert B Gerbing, Lisa Brodersen, Michael Loken, Alan Gamis, Richard Aplenc, Todd A Alonzo, Edward Anders Kolb
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival. Cancers 14 (3) (2022)
Lauren Pommert, Eric S Schafer, Jemily Malvar, Nathan Gossai, Ellynore Florendo, Kirthi Pulakanti, Katelyn E Heimbruch, Cary Stelloh, Yueh-Yun Chi, Richard Sposto, Sridhar Rao, Van Thu Huynh, Patrick Brown, Bill H Chang, Susan I Colace, Michelle L Hermiston, Kenneth Heym, Raymond J Hutchinson, Joel A Kaplan, Rajen Mody, Tracey A O'Brien, Andrew E Place, Peter H Shaw, David S Ziegler, Alan Wayne, Deepa Bhojwani, Michael J Burke
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. American journal of hematology 97 (5) (2022)
Eric S Schafer, Karen Chao, Alexandra M Stevens, Eunji Jo, Susan G Hilsenbeck, Nathan P Gossai, Andrew Doan, Susan I Colace, Terri Guinipero, Daniel Otterson, Joel A Kaplan, Ashley Hinson, Lauren Pommert, Alan S Wayne, Deepa Bhojwani, Michael J Burke
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatric blood & cancer 69 (10) (2022)
Jeremy D Rubinstein, Rachana Shah, Erin H Breese, Karen C Burns, Jennifer L Mangino, Robin E Norris, Lynn Lee, Benjamin Mizukawa, Maureen M O'Brien, Christine L Phillips, John P Perentesis, Lauren Pommert, Michael J Absalon
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective. Pediatric blood & cancer 68 (8) (2021)
Lauren Pommert, Robert Burns, Quinlan Furumo, Kirthi Pulakanti, Jon Brandt, Michael J Burke, Sridhar Rao
Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia. Cancer reports (Hoboken, N.J.) 4 (3) (2021)